Singh A - Search Results

1

Immuno-engineering: The Next Frontier in Therapeutics Delivery.

Singh A, Roy K. Singh A, et al. Adv Drug Deliv Rev. 2017 May 15;114:1-2. doi: 10.1016/j.addr.2017.08.005. Adv Drug Deliv Rev. 2017. PMID: 28865770 No abstract available.

2

Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells.

Singh A, Nie H, Ghosn B, Qin H, Kwak LW, Roy K. Singh A, et al. Mol Ther. 2008 Dec;16(12):2011-21. doi: 10.1038/mt.2008.206. Epub 2008 Sep 23. Mol Ther. 2008. PMID: 18813280 Free article.

3

In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells.

Singh A, Suri S, Roy K. Singh A, et al. Biomaterials. 2009 Oct;30(28):5187-200. doi: 10.1016/j.biomaterials.2009.06.001. Epub 2009 Jun 27. Biomaterials. 2009. PMID: 19560815 Free PMC article.

4

Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA.

Ghosn B, Singh A, Li M, Vlassov AV, Burnett C, Puri N, Roy K. Ghosn B, et al. Among authors: singh a. Oligonucleotides. 2010 Jun;20(3):163-72. doi: 10.1089/oli.2010.0235. Oligonucleotides. 2010. PMID: 20565242

5

An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma.

Singh A, Qin H, Fernandez I, Wei J, Lin J, Kwak LW, Roy K. Singh A, et al. J Control Release. 2011 Oct 30;155(2):184-92. doi: 10.1016/j.jconrel.2011.06.008. Epub 2011 Jun 21. J Control Release. 2011. PMID: 21708196

6

Engineering vaccines and niches for immune modulation.

Purwada A, Roy K, Singh A. Purwada A, et al. Among authors: singh a. Acta Biomater. 2014 Apr;10(4):1728-40. doi: 10.1016/j.actbio.2013.12.036. Epub 2013 Dec 27. Acta Biomater. 2014. PMID: 24373907 Review.

7

Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.

Stephenson R, Singh A. Stephenson R, et al. Among authors: singh a. Adv Drug Deliv Rev. 2017 May 15;114:285-300. doi: 10.1016/j.addr.2017.06.010. Epub 2017 Jun 15. Adv Drug Deliv Rev. 2017. PMID: 28625826 Free PMC article. Review.

8

Microbiome as an immune regulator in health, disease, and therapeutics.

Juarez VM, Montalbine AN, Singh A. Juarez VM, et al. Among authors: singh a. Adv Drug Deliv Rev. 2022 Sep;188:114400. doi: 10.1016/j.addr.2022.114400. Epub 2022 Jun 16. Adv Drug Deliv Rev. 2022. PMID: 35718251 Free PMC article. Review.

9

Lipid Membrane-Based Antigen Presentation to B Cells Using a Fully Synthetic Ex Vivo Germinal Center Model.

Kramer L, Song HW, Mitchell K, Kartik M, Jain R, Escarra VL, Quiros E, Fu H, Singh A, Roy K. Kramer L, et al. Among authors: singh a. Adv Nanobiomed Res. 2022 Jul;2(7):2100137. doi: 10.1002/anbr.202100137. Epub 2022 Apr 28. Adv Nanobiomed Res. 2022. PMID: 35937779 Free PMC article.

10

Self-Assembly Protein Nanogels for Safer Cancer Immunotherapy.

Purwada A, Tian YF, Huang W, Rohrbach KM, Deol S, August A, Singh A. Purwada A, et al. Among authors: singh a. Adv Healthc Mater. 2016 Jun;5(12):1413-9. doi: 10.1002/adhm.201501062. Epub 2016 Apr 21. Adv Healthc Mater. 2016. PMID: 27100566 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,048 results

Search Page